BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parra RS, Feitosa MR, Machado VF, Ramalho LN, da Rocha JJ, Feres O. Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report. J Med Case Rep 2015;9:249. [PMID: 26518665 DOI: 10.1186/s13256-015-0730-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gîlcă GE, Diaconescu S, Bălan GG, Timofte O, Ştefănescu G. Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report. Medicine (Baltimore) 2017;96:e6156. [PMID: 28272203 DOI: 10.1097/MD.0000000000006156] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
2 Tripathi K, Feuerstein JD. New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance. Drugs Context 2019;8:212572. [PMID: 31065290 DOI: 10.7573/dic.212572] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
3 Shamberg L, Vaziri H. Hepatotoxicity of Inflammatory Bowel Disease Medications. Journal of Clinical Gastroenterology 2018;52:674-84. [DOI: 10.1097/mcg.0000000000001084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
4 Kleiner DE. Recent Advances in the Histopathology of Drug-Induced Liver Injury. Surg Pathol Clin. 2018;11:297-311. [PMID: 29751876 DOI: 10.1016/j.path.2018.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
5 Shah P, Sundaram V, Björnsson E. Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review. Hepatol Commun 2020;4:172-84. [PMID: 32025603 DOI: 10.1002/hep4.1465] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
6 Becker MW, Lunardelli MJM, Tovo CV, Blatt CR. Drug and herb-induced liver injury: A critical review of Brazilian cases with proposals for the improvement of causality assessment using RUCAM. Ann Hepatol. 2019;18:742-750. [PMID: 31130470 DOI: 10.1016/j.aohep.2019.03.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
7 Kok B, Lester ELW, Lee WM, Hanje AJ, Stravitz RT, Girgis S, Patel V, Peck JR, Esber C, Karvellas CJ; United States Acute Liver Failure Study Group. Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature Review. Dig Dis Sci 2018;63:1654-66. [PMID: 29564668 DOI: 10.1007/s10620-018-5023-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]